Author:
Devi Akyana Seeta,Dumbre Dipali
Abstract
The prevalence of COVID 19 disease cases in India stands too high; this disease is caused by the coronavirus called SARS-CoV-2. Noval coronavirus virus was firstly detected in a group of people suffering from Pneumonia in Wuhan, China. Several studies are conducted to understand the different aspects of novel coronavirus SARS-CoV-2 in causing severe respiratory infections. However, the impact of risk factors on the severity of the symptoms and outcome of COVID 19 is not clearly understood. Similarly, most studies reported that patients who suffer from comorbidities with COVID 19 had a poor prognosis. Most COVID 19 patients who had preexisting medical conditions such as hypertension, diabetes, obesity, smoking habit, etc., required ICU admission and mechanical ventilation. On the other hand, studies reported that COVID 19 infection is responsible for causing the predominant cardiovascular diseases due to myocardial damage, thromboembolism arrhythmias, and ACS.
Reference47 articles.
1. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020: World Health Organisation; 2020.
2. Li BO, Yang J, Zhao F, et al. prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020; 109(5): 531- 538.
3. Diabetes atlas: international diabetes federation 2019, 9th. https://www.diabetesatlas.org/en/
4. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020; 24: 91- 98.
5. Wilson N, Corbett S, Tovey E. Airborne transmission of covid-19. BMJ. 2020; 370: m3206.